Antidiuretic Hormone Receptor Antagonists ; Tolvaptan Vasopressin V1a receptor, target ; Satavaptan Vasopressin V2 receptor, target ; Balovaptan Vasopressin
Vasopressin-receptor antagonists. Vasopressin-receptor antagonists (VPAs) are a new class of drugs. These drugs block the action of vasopressin at one of its receptor sites. Vasopressin has several physiological functions in addition to its antidiuretic effects.
Vasopressin antagonists are drugs that bind to vasopressin receptors (V1A, V1B and V2) and block the action of vasopressin (antidiuretic hormone, ADH), which is a hormone released by the pituitary gland. Vasopressin causes vasoconstriction and increases reabsorption of water by the kidneys.
by A Parashar 2024 Cited by 6Vasopressin receptor antagonists Vasopressin Physiology Vasopressin Receptors Vasopressin Receptor Antagonists Conivaptan (YM-087).
What are Vasopressin antagonists? Vasopressin antagonists are drugs that bind to vasopressin receptors (V1A, V1B and V2) and block the action of vasopressin (
Vasopressin antagonists are drugs that bind to vasopressin receptors (V1A, V1B and V2) and block the action of vasopressin (antidiuretic hormone, ADH).
Vasopressin antagonists are drugs that block the action of vasopressin, a hormone that regulates blood pressure and water balance. They are used to treat hyponatremia in congestive heart failure patients. See list of vasopressin antagonists and their ratings.
Vasopressin antagonists are drugs that bind to vasopressin receptors (V1A, V1B and V2) and block the action of vasopressin (antidiuretic hormone, ADH), which is a hormone released by the pituitary gland.
Vasopressin antagonists are drugs that bind to vasopressin receptors (V1A, V1B and V2) and block the action of vasopressin (antidiuretic hormone, ADH)
Comments